| Bioactivity | IDO1-IN-18 (Compound 14) is a potent inhibitor of IDO1. IDO1-IN-18 has the potential for the research of cancer diseases[1]. | ||||||||||||
| Name | IDO1-IN-18 | ||||||||||||
| CAS | 2328099-08-5 | ||||||||||||
| Formula | C23H18F4N2O3 | ||||||||||||
| Molar Mass | 446.39 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Derun Li, et al. Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing. |
IDO1-IN-18
CAS: 2328099-08-5 F: C23H18F4N2O3 W: 446.39
IDO1-IN-18 (Compound 14) is a potent inhibitor of IDO1. IDO1-IN-18 has the potential for the research of cancer diseases
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.